Clinical Nuclear Medicine · 2011 · 77 citations · 17 references
MedicineNuclear MedicineRadiologyDiagnostic ImagingDiagnostic RadiologyNeuroradiologyBrain ImagingBrain TumorsMagnetic Resonance ImagingNeuro-oncology ImagingPositron Emission TomographyRadiation TherapyBrain Tumor DiagnosisBrain Tumor PathologyMultimodal Medical ImagingOncologic Pet ImagingPet-computed TomographyPet-magnetic Resonance ImagingRadiation-associated Brain TumorsSensitivity
OBJECTIVE: To compare potentials of magnetic resonance imaging (MRI), F-18 FDG, and 11C-Choline PET/CT in differentiating brain tumor recurrence from necrosis after radiotherapy. METHODS: Fifty-five patients with suspected brain tumor recurrence or necrosis after radiotherapy underwent MRI, F-18 FDG, and 11C-choline PET/CT examinations, and all the patients were followed up for at least 11 months. Lesion diagnoses based on medical imaging were compared with pathology or follow-up outcomes. RESULTS: The sensitivities of MRI, F-18 FDG PET/CT, and 11C-Choline PET/CT in lesion diagnosis were 87.2%, 76.9%, and 92.3%, respectively, and their specificities were 81.3%, 62.5%, and 87.5%, respectively. CONCLUSION: The results suggest that 11C-Choline PET/CT with higher sensitivity and specificity may be better in distinguishing recurrent brain tumor from radionecrosis compared with F-18 FDG PET/CT and MRI.
17
Radiation injury of the brain.
Peter E. Valk, W.P. Dillon · PubMed · 1991 · 285 citations · Full text
Brain radiation lesions: MR imaging.
Grégoire Dooms, S T Hecht, Michael Brant‐Zawadzki et al. · Radiology · 1986 · 270 citations